Prandin

Medicinal product

(Invented) name

Prandin

Active substance (s)

Repaglinidas

Strength

0,5 mg

Pharmaceutical form

tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

A10BX02, Repaglinide

Marketing authorisation holder

Novo Nordisk A/S, Danija

Date of authorisation

2001-01-29

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

10c

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

tablet	1 vnt.
Repaglinidas	0,5 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
27832	30374	1030374	lizdinė plokštelė	N30		Receptinis	EU/1/00/162/003	Netiekiama	-	-	No	-	-
27833	30375	1030375	lizdinė plokštelė	N90		Receptinis	EU/1/00/162/004	Netiekiama	-	-	No	-	-
27834	30376	1030376	lizdinė plokštelė	N120		Receptinis	EU/1/00/162/005	Netiekiama	-	-	No	-	-
27836	30378	1030378	buteliukas	N270		Receptinis	EU/1/00/162/021	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2001-01-29	Registruotas